Adda247 vs Medify
Adda247
adda247.comMedify
medify.coSide by side
| Figure | Adda247 | Medify |
|---|---|---|
| Price from | ₹299/mo | £0.34/mo |
| Free plan | — | Yes |
| Free trial | — | — |
| Open source | — | — |
| Web | Yes | Yes |
| iOS | Yes | Yes |
| Android | Yes | Yes |
| Plans published | 2 | 4 |
| Spec score · Exam Prep Apps | 8.2 (#52) | 8.8 (#8) |
| Exam scope | multiple_exam_types | multiple_exam_types |
| Founded | 2016 | 2009 |
| Free plan | Yes | Yes |
| Full-length mock tests | Yes | Yes |
| Headquarters | Gurugram, Haryana, India | London, England |
| Platform support | Web, iOS, Android | Web; mobile web |
| Privacy and security | The privacy policy says Adda247 uses technical and organizational safeguards, including encryption and physical security measures, while stating it cannot guarantee database or transmission security. | Medify says stored information and payment transactions are encrypted, access to personal data is limited to authorised personnel, and its computer systems are encrypted and password protected. |
| Support | Adda247 advertises 24×7 customer support and lists a support link on its site. | Medify directs users with questions or suggestions to contact its team by email. |
Plans
Adda247
- Monthly Saver Plan₹1,300 a month
- Monthly Saver Plan — Bank Subscription Pack 2026₹299 a month
In their own words
Medify
Medify is a web-based study platform for preparing for UCAT, GAMSAT, interviews, and A Levels. Its question bank contains 20,000 questions, and full-length mock tests are available. The paid plans list the same course areas, along with practice questions with explanations, mock exams, and performance analytics. A free plan includes study notes, a guidebook, and a work experience map. The platform supports web and mobile web access. The Free plan costs nothing. Weekly costs £15 a month, Monthly costs £30 a month, and Yearly costs £210 a year. The Weekly plan lists the full UCAT, GAMSAT, Interviews, and A Levels courses, as do the Monthly and Yearly plans. Medify was founded in 2009 and is based in London, England.